Intuitive Surgical Q4 Earnings: Revenue Beat, EPS Beat, Da Vinci Procedures Jump 18% And More
Generado por agente de IAMarcus Lee
jueves, 23 de enero de 2025, 5:18 pm ET1 min de lectura
ISRG--
Intuitive Surgical (ISRG) reported strong fourth-quarter earnings, with revenue and earnings per share (EPS) both beating analyst estimates. The company's da Vinci surgical system placements and procedures grew significantly, driving the positive results. Here's a breakdown of the key financials and growth drivers:
Financial Highlights:
* Revenue: $2.41 billion, up 25% year-over-year (YoY)
* EPS: $2.21, up 23% YoY
* GAAP net income: $686 million, up 10% YoY
* Non-GAAP net income: $805 million, up 27% YoY
Growth Drivers:
1. Da Vinci Surgical System Placements: Intuitive Surgical placed 493 da Vinci systems in the fourth quarter, a 19% increase YoY. This includes 174 da Vinci 5 systems, which are the latest version of the company's surgical robot. The increase in placements contributed to the growth in procedures and revenue.
2. Da Vinci Procedures: Worldwide da Vinci procedures grew approximately 18% compared to the same period last year. This growth was driven by an increase in general surgery procedures in the U.S. and a 23% increase in total procedures outside the U.S., primarily in cancer procedures.
3. Installed Base: The company's da Vinci surgical system installed base grew to 9,902 systems as of December 31, 2024, a 15% increase YoY. This larger installed base allows for more procedures to be performed, further driving revenue growth.

Intuitive Surgical's strong fourth-quarter results reflect the continued demand for its minimally invasive surgical systems and the company's ability to adapt to the evolving needs of the market. The growth in da Vinci system placements and procedures, combined with the expansion of the installed base, sets the stage for increased revenue in the coming years.
Looking ahead, Intuitive Surgical expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025 compared to 2024. The company's continued investment in research and development, marketing, and sales efforts, along with its strong financial performance, positions it well for future growth.
In conclusion, Intuitive Surgical's fourth-quarter earnings beat analyst estimates, driven by strong growth in da Vinci surgical system placements and procedures. The company's positive results reflect its ability to adapt to the evolving needs of the market and its continued investment in research and development. With a larger installed base and expectations of continued procedure volume growth, Intuitive Surgical's future revenue potential is strengthened.
Intuitive Surgical (ISRG) reported strong fourth-quarter earnings, with revenue and earnings per share (EPS) both beating analyst estimates. The company's da Vinci surgical system placements and procedures grew significantly, driving the positive results. Here's a breakdown of the key financials and growth drivers:
Financial Highlights:
* Revenue: $2.41 billion, up 25% year-over-year (YoY)
* EPS: $2.21, up 23% YoY
* GAAP net income: $686 million, up 10% YoY
* Non-GAAP net income: $805 million, up 27% YoY
Growth Drivers:
1. Da Vinci Surgical System Placements: Intuitive Surgical placed 493 da Vinci systems in the fourth quarter, a 19% increase YoY. This includes 174 da Vinci 5 systems, which are the latest version of the company's surgical robot. The increase in placements contributed to the growth in procedures and revenue.
2. Da Vinci Procedures: Worldwide da Vinci procedures grew approximately 18% compared to the same period last year. This growth was driven by an increase in general surgery procedures in the U.S. and a 23% increase in total procedures outside the U.S., primarily in cancer procedures.
3. Installed Base: The company's da Vinci surgical system installed base grew to 9,902 systems as of December 31, 2024, a 15% increase YoY. This larger installed base allows for more procedures to be performed, further driving revenue growth.

Intuitive Surgical's strong fourth-quarter results reflect the continued demand for its minimally invasive surgical systems and the company's ability to adapt to the evolving needs of the market. The growth in da Vinci system placements and procedures, combined with the expansion of the installed base, sets the stage for increased revenue in the coming years.
Looking ahead, Intuitive Surgical expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025 compared to 2024. The company's continued investment in research and development, marketing, and sales efforts, along with its strong financial performance, positions it well for future growth.
In conclusion, Intuitive Surgical's fourth-quarter earnings beat analyst estimates, driven by strong growth in da Vinci surgical system placements and procedures. The company's positive results reflect its ability to adapt to the evolving needs of the market and its continued investment in research and development. With a larger installed base and expectations of continued procedure volume growth, Intuitive Surgical's future revenue potential is strengthened.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios